Both in Pharmaceuticals
Lifecore Biomedical vs Standard BioTools
Over the past year LFCR returned −10.0% and LAB returned −50.8%; their daily moves had a correlation of 0.09.
LFCR −10.0% LAB −50.8%Growth of $1, one year, split-adjusted
| Metric | LFCR | LAB |
|---|---|---|
| Price | $6.40 | $0.6100 |
| Market cap | $242.6M | $240.8M |
| Today | −1.84% | −1.61% |
| 1 month | −2.0% | −16.2% |
| 6 months | +21.7% | −34.8% |
| Year to date | −21.8% | −52.3% |
| 1 year | −9.3% | −48.7% |
| Revenue growth (YoY) | — | −7.6% |
| Gross margin | 35.3% | 52.4% |
| Net margin | −20.9% | −133.1% |
| P/E (TTM) | — | 2.8× |
| Price / sales | — | 2.8× |
| Net cash | -$136.9M | $476.4M |
| Dividend yield | — | — |
| Volatility (60d) | 98.4% | 45.5% |
| Short % of float | 6.5% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).